Attention:

Certain features of Sigma-Aldrich.com will be down for maintenance the evening of Friday August 18th starting at 8:00 pm CDT until Saturday August 19th at 12:01 pm CDT.   Please note that you still have telephone and email access to our local offices. We apologize for any inconvenience.

Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes

SDS

Search for SDS (Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides

Redi-Dri™ for Free-Flowing Hygroscopic Powders

Redi-Dri packaging system eliminates clumping typically noted with many hygroscopic powders and provides a free-flowing, ready-to-use material.

Contact Us

Customer Service: 800-325-3010

Email Subscription Center

To receive the information that is relevant to your work, explore our subscription center and set your preferences

Global Citizenship

Learn more about our commitment to people, green chemistry and the environment

About Us

Our life science business features a portfolio of more than 300,000 products enabling scientific discovery.

Vetec Quimica

The acquisition of Vetec Quimica is part of Sigma-Aldrich's strategy to continue building a presence in the emerging markets.

News & Information

Country Information

Billerica, Massachusetts - August 8, 2017 MilliporeSigma and Baylor College of Medicine Advance Vaccine Development and Manufacturing for Neglected Diseases

MilliporeSigma today announced that it has formed a strategic alliance with Baylor College of Medicine, Houston, Texas, and its vaccine product development partnership (PDP), Texas Children’s Hospital Center for Vaccine Development (Texas Children’s CVD), to advance vaccine research and development for neglected and emerging infections.

Read More
Billerica, Massachusetts - August 3, 2017 European Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology

MilliporeSigma today announced that the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for MilliporeSigma’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells.

Read More
Billerica, Massachusetts - June 27, 2017 MilliporeSigma Wins False Advertising Lawsuit Against Distributor of RephiLe Bioscience Lab Water Products

MilliporeSigma today announced that it has prevailed against Analis S.A. in a lawsuit ordering the Belgium-based laboratory equipment distributor to cease advertising that compares RephiLe Bioscience Ltd.’s lab water products with the lab water products of MilliporeSigma.

Read More